文献速递腹部泌尿生殖CTDRPET

评估迭代图像重建在肾和肝供者中的应用:自适应迭代剂量降低3D(AIDR 3D)技术的潜在作用

Assessment of iterative image reconstruction on kidney and liver donors: Potential role of adaptive iterative dose reduction 3D (AIDR 3D) technology.
PubMed 文献 · Eur J Radiol · 2018-10-28

前瞻性随机纳入60名肾和肝供者,比较全剂量与低剂量CT方案(采用AIDR 3D迭代重建)的辐射剂量和图像噪声。肾供者低剂量组有效剂量较全剂量组降低37%,肝供者降低48%,图像噪声指数无统计学显著差异。作者建议对供者进行临床和放射生物学监测。

要点

  • 肾供者低剂量方案有效剂量18.9 mSv,较全剂量49.0 mSv降低37%,图像噪声无显著差异。
  • 肝供者低剂量方案有效剂量21.6 mSv,较全剂量43.3 mSv降低48%,图像噪声无显著差异。
  • AIDR 3D迭代重建可在维持可接受图像质量的同时降低供者CT辐射剂量。

核心结论

  • 肾和肝供者因诊断评估和管理承受相对显著的辐射剂量;使用AIDR 3D的CT迭代重建是有价值的剂量降低工具,肾供者降低37%、肝供者降低48%,同时维持可接受的图像质量;建议对这些受试者进行临床和放射生物学水平监测。

研究设计与样本

  • 前瞻性随机招募60名受试者(40男20女,平均年龄35±10岁),等分为肾供者组(24男6女)和肝供者组(21男9女);肾供者再分为全剂量组(KFD,n=20)和低剂量组(KLD,n=10),行Tc99m-DTPA动态肾扫描、CT肾动脉造影和X线平片;肝供者分为全剂量组(LFD,n=20)和低剂量组(LLD,n=10),行CT肝脏体积测量;比较全剂量与低剂量方案的CTDIvol、DLP、总mAs、有效剂量和图像噪声指数。

诊断标准与关键数值

  • 肾供者全剂量组vs低剂量组:mAs 16386.8±3140.7 vs 2830.286±831.676,CTDIvol 183.19±32.58 mGy vs 45.5±13.3 mGy,DLP 2884±859.0 mGy·cm vs 1437.5±399 mGy·cm,有效剂量49.0±9.0 mSv vs 18.9±5.7 mSv,均p<0.0005。
  • 肝供者全剂量组vs低剂量组:mAs 14348.8±4571.8 vs 3123.357±794.5,CTDIvol 333.6±59.5 mGy vs 51.4±13 mGy,DLP 3268.3±604.3 mGy·cm vs 1260.5±404.6 mGy·cm,有效剂量43.3±12.9 mSv vs 21.6±5.9 mSv,均p<0.0005。
  • 肾供者全剂量组vs低剂量组及肝供者全剂量组vs低剂量组的图像质量噪声指数比较均无统计学显著性(p>0.05)。
  • AIDR 3D迭代重建使肾供者剂量降低37%,肝供者剂量降低48%。

临床应用与阅片要点

  • 作者建议对肾和肝供者在临床和放射生物学水平进行监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to evaluate the radiation exposure levels in two different types of subjects including liver and kidney donors in diagnostic assessment of transplant operation and also the significance of dose reduction on total effective dose.

MATERIALS AND METHODS: A number of Sixty subjects (40 males and 20 females, average age of 35 ± 10 years) were randomly prospectively recruited and equally divided into two distinct groups namely kidney donors (KD, 24 M and 6 F) and liver donors (LD, 21 M and 9 female). Kidney donors were divided into full dose (KFD, n = 20) group and low dose (KLD, n = 10) group. They had undergone dynamic renal scan using Tc99 m-DTPA, CT renal angiography and x-ray plain radiograph. Liver donors were divided into full dose (LFD, n = 20) and low dose (LLD, n = 10) groups and performed CT liver volumetry. The CT dose index (CTDIvol), dose length product (DLP), total milli-ampere product time mAs, effective dose and image noise index were measured in all subjects of kidney and liver donors comparing full dose and low dose protocols.

RESULTS: In comparison of all subjects of kidney donor groups (KFD vs KLD), the parameters (mAs = 16386.8 ± 3140.7 vs 2830.286 ± 831.676), (CTDIvol = 183.19 ± 32.58 mGy vs. 45.5 ± 13.3 mGy), DLP = 2884 ± 859.0 mGy.cm vs. 1437.5 ± 399 mGy.cm) and (effective dose = 49.0 ± 9.0 mSv vs. 18.9 mSv±5.7 mSv) were significant, p < 0.0005. Statistical evaluation of liver donors groups (LFD vs LLD) showed that (mAs = 14348.8 ± 4571.8 vs 3123.357 ± 794.5), (CTDIvol = 333.6 ± 59.5 mGy vs. 51.4 ± 13 mGy), (DLP = 3268.3 ± 604.3 mGy.cm vs 1260.5 ± 404.6 mGy.cm) and (effective dose = 43.3 mSv±12.9 mSv vs. 21.6 ± 5.9 mSv) are statistically significant, p < 0.0005. Nevertheless, the comparative evaluation of the image quality noise index of KFD vs KLD groups and LFD vs LLD showed a no statistical significance p > 0.05.

CONCLUSION: Renal and liver donors bear a relatively significant radiation dose due to diagnostic evaluation and patient management. The CT iterative reconstruction using AIDR3D proved very valuable tool in dose reduction such that it can reduce 37% in kidney donors and 48% in liver donors while able to maintain an acceptable image quality. Monitoring of those subjects on the clinical and radiobiological levels are recommended.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Maamoun I, Khalil MM. Assessment of iterative image reconstruction on kidney and liver donors: Potential role of adaptive iterative dose reduction 3D (AIDR 3D) technology. Eur J Radiol. 2018. PMID: 30527293. doi:10.1016/j.ejrad.2018.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。